Gyeonggi-do, South Korea

Na Hee Lee

This inventor holds 1 USPTO granted patent. Top assignee: Samsung Life Public Welfare Foundation. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Na Hee Lee: Innovator in Stem Cell Therapeutics

Introduction

Na Hee Lee is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of stem cell research, particularly in enhancing the therapeutic effects of stem cells. Her innovative work has the potential to improve medical treatments and patient outcomes.

Latest Patents

Na Hee Lee holds a patent titled "Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same." This invention relates to a composition designed to enhance the survival rate of stem cells by including an immunosuppressant. The composition aims to overcome immune responses caused by the administration of xenogeneic cells, thereby improving the stability and efficacy of stem cells. This advancement could lead to the development of mesenchymal stem cell therapeutic agents that maximize the therapeutic effects of stem cells.

Career Highlights

Na Hee Lee is associated with the Samsung Life Public Welfare Foundation, where she continues to pursue her research and development efforts. Her work is focused on creating innovative solutions that can significantly impact the field of regenerative medicine.

Collaborations

Na Hee Lee collaborates with notable colleagues, including Jong Wook Chang and Jung Won Hwang. These partnerships enhance her research capabilities and contribute to the advancement of stem cell therapies.

Conclusion

Na Hee Lee's contributions to stem cell research exemplify the importance of innovation in medical science. Her patented work has the potential to revolutionize therapeutic approaches and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…